Although different Elongator pathogenic variants share NDD clinical features, we have recently demonstrated by modelling disease-associated ELP2 and ELP6 variants in mice that mutations in the two subcomplexes affect different brain cells during development [5]. This evidence concerns the gene ELP2 and Neurodevelopmental delay.